NPS Pharmaceuticals (NPSP)

[surf1944]

7:13AM NPS Pharm: FDA advisory committee to review Gattex new drug application for the treatment of adults with short bowel syndrome (NPSP) 10.19 : Co announced that NASDAQ has halted trading of the company's common stock. The U.S. FDA Gastrointestinal Drugs Advisory Committee is meeting today to review Gattex, a novel, recombinant analog of human glucagon-like peptide 2 being developed for the treatment of adults with short bowel syndrome. The Gastrointestinal Drugs Advisory Committee reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of gastrointestinal diseases and makes appropriate recommendations to the FDA. (shares halted)